Frank L. Chen

Director


Associate Director Santen Ventures Inc
Digital and Device Investment Lead

Mr. Chen is currently leading Digital and Device investments for Santen Ventures, Inc. (SVI), a corporate venture arm within Santen Pharmaceutics. He has been at Santen since 2015 building innovation capabilities internally and transferring to SVI after helping to create the original fund. Mr. Chen has experience in startups and large corporations as well as medical device and pharmaceuticals. His goal is to help active investment companies as a strategic board director or observer.

Mr. Chen earned his B.S. for Physiology and Neurology from the University of California, San Diego and an M.B.A from the Marshall School of Business at the University of Southern California.

Note: LaserACE® is not yet FDA approved or available in the United States. It is currently in clinical trials only in select areas outside of the United States.

Ace Vision Group, Inc.
39655 Eureka Dr, Newark, CA 94560
Telephone: 234-738-4074
234-738-4074

Ace Vision See Life NaturallyTM, LaserACE® and VisioLite® are registered trademarks of Ace Vision Group, Inc. All rights reserved. 2008-2020.